Does CAPLACIZUMAB Cause Condition aggravated? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Condition aggravated have been filed in association with CAPLACIZUMAB (Cablivi). This represents 9.0% of all adverse event reports for CAPLACIZUMAB.
13
Reports of Condition aggravated with CAPLACIZUMAB
9.0%
of all CAPLACIZUMAB reports
5
Deaths
8
Hospitalizations
How Dangerous Is Condition aggravated From CAPLACIZUMAB?
Of the 13 reports, 5 (38.5%) resulted in death, 8 (61.5%) required hospitalization, and 2 (15.4%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Haemorrhage (9)
Deep vein thrombosis (8)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which CAPLACIZUMAB Alternatives Have Lower Condition aggravated Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL